alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
State of Utah 

GARY R. HERBERT 

Governor 

SPENCER J. COX 

Lieutenant Governor 

December 10, 2015 

Department of 

Environmental Quality 

Alan Matheson 

Executive Director 

DIVISION OF AIR QUALITY 

Bryce C. Bird 

Director 

Carl Daly, Air Program Director 

U.S. Environmental Protection Agency, Region 8 (8P-AR) 

1595 Wynkoop Street 

Denver, Colorado 80202 

Dear Mr. Daly: 

DAQP-120-15 

The purpose of this letter is to acknowledge a deficiency in Utah's state implementation plan 

(SIP) revisions for regional haze (adopted by the Utah Air Quality Board on June 3, 2015) related 

to particulate matter (PM) reporting and to commit to submit, upon final adoption by the Utah Air 

Quality Board, a revision to correct the deficiency. 

During review of Utah's regional haze SIP submittal, the Environmental Protection Agency 

(EPA) noted a deficiency in the reporting requirements for PM. The current language (submitted 

to EPA on June 4, 2015) in SIP Section IX.H.21 requires sources to report excess PM emissions 

resulting only from breakdowns (R307-107-2). 

The Utah Division of Air Quality (UDAQ) acknowledges that the PM reporting requirements 

applicable to the state's regional haze rule should be revised. Below is an example revision to 

Section IX.H.21 ( e) of Utah's SIP that would require reporting of all deviations from PM emission 

limitations: 

"Each source shall submit a report of any deviation from the applicable requirements of 

Subsection IX.H, including those attributable to upset conditions, the probable cause of such 

deviations, and any corrective actions or preventive measures taken. The report shall be 

submitted to the Director no later than 24-months following the deviation, or earlier, as 

specified by an underlying applicable requirement. Deviations due to breakdowns shall be 

reported according to the breakdown provisions of R307-107." 

195 North 1950 West• Salt Lake City, UT 

Mailing Address: P.O. Box 144820 •Salt Lake City, UT 84114-4820 

Telephone (801) 536-4000 •Fax (801)536-4099 • T.D.D. (801) 903-3978 

www deq utah.gov 

Printed on I 00% recycled paper 
DAQP-120-15 

Page2 

The UDAQ commits to working with the Utah Air Quality Board to approve this revision to State 

rules so that it is applicable to sources subject to IX.H22. Source Specific Emission Limitatiorzs: 

Regional Haze Requirements, Best Available Retrofit Technology. Further, UDAQ commits to 

submitting this revision to EPA within one year ofEPA's final action on the June 3, 2015, SIP 

revisions. 

If you have any questions, please contact Jay Baker of my staff at (801) 536-4015. 

Bryce C. Bird 

Director
I 

109TH CONGRESS 

2D SESSION H. R. 4937 

To amend part D of title XVIII of the Social Security Act to provide 

for continuity of coverage of prescription drugs under Medicare prescription drug plans for full-benefit dual eligible individuals. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 9, 2006 

Mrs. WILSON of New Mexico introduced the following bill; which was referred 

to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined 

by the Speaker, in each case for consideration of such provisions as fall 

within the jurisdiction of the committee concerned 

A BILL 

To amend part D of title XVIII of the Social Security 

Act to provide for continuity of coverage of prescription 

drugs under Medicare prescription drug plans for fullbenefit dual eligible individuals. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. MEDICARE CONTINUITY OF COVERAGE OF PRE4 SCRIPTION DRUGS FOR FULL-BENEFIT DUAL 

5 ELIGIBLE INDIVIDUALS. 

6 (a) IN GENERAL.—Section 1860D–2(a) of the Social 

7 Security Act (42 U.S.C. 1395w–102(a)) is amended— 


ycherry on PROD1PC64 with BILLS
2 

•HR 4937 IH 

1 (1) in paragraph (1), by inserting ‘‘subject to 

2 paragraph (6),’’ after ‘‘part C’’; and 

3 (2) by adding at the end the following new 

4 paragraph: 

5 ‘‘(6) CONTINUATION OF COVERAGE FOR FULL6 BENEFIT DUAL ELIGIBLE INDIVIDUALS

7 TRANSITIONING FROM MEDICAID COVERAGE.—In the 

8 case of an individual who, as of date the individual 

9 is first enrolled under a prescription drug plan under 

10 this part (or an MA–PD plan under part D), is a 

11 full-benefit dual eligible individual and is being pro12 vided medical assistance for a prescription drug or 

13 biological under title XIX that may be covered as a 

14 covered part D drug under this part, qualified pre15 scription drug coverage must include coverage for 

16 such drug without the application of coverage limita17 tions, such as prior authorization or quantity limits, 

18 unless a prescribing physician certifies that the cov19 erage of such drug is not medically necessary, re20 gardless of whether the individual subsequently re21 mains a full-benefit dual eligible individual.’’. 

22 (b) EFFECTIVE DATE.—The amendments made by 

23 subsection (a) shall be effective as if included in the enactVerDate Aug 31 2005 04:36 Mar 10, 2006 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H4937.IH H4937

ycherry on PROD1PC64 with BILLS
3 

•HR 4937 IH 

1 ment of Medicare Prescription Drug, Improvement, and 

2 Modernization Act of 2003 (Public Law 108–173). 

Æ 


ycherry on PROD1PC64 with BILLS
# C_2017339EN.01000201.xml

| 10.10.2017 | EN | Official Journal of the European Union | C 339/2 |
| --- | --- | --- | --- |

10.10.2017

EN

Official Journal of the European Union

C 339/2

---

Non-opposition to a notified concentration

(Case M.8604 — Xella International/Ursa)

(Text with EEA relevance)

(2017/C 339/03)

On 4 October 2017, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32017M8604. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32017M8604. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
EX-32 14 dex32.htm CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906
Exhibit 32

Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each
of the undersigned officers of Alpha Nutraceuticals, Inc., a California
corporation, does hereby certify, to such officer's knowledge, that the
Annual Report on Form 10-K for the fiscal year ended December 31, 2004 of
Alpha Nutraceuticals, Inc. fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
78o(d)) and that information contained in such report fairly presents, in
all material respects, the financial condition and results of operations of
Alpha Nutraceuticals, Inc.

Date: March 29, 2004


/s/ Louis Paulsen

Louis Paulsen, Chief Executive
Officer
Date: March 29, 2004

/s/ James Cartmill

James Cartmill, Chief Financial
Officer

The foregoing certification is furnished solely pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350,
Chapter 63 of Title 18, United States Code) and is not being filed as part
of the Form 10-K or as a separate disclosure document
CLARK, II v. JOYNER, et al.

17P19-1

Supreme Court of North Carolina.

March 27, 2019

Daniel P. O'Brien, Special Deputy Attorney General, For NC Dept. of Public Safety

Joseph Earl Clark, II, For Clark, Joseph Earl (II)

The following order has been entered on the motion filed on the 10th of January 2019 by Petitioner for Petition for Discretionary Review:

"Motion Denied by order of the Court in conference, this the 27th of March 2019."
No. 09-9574.

#### Anne F. Edwards, Petitioner v. Astoria Federal Savings.

560 U.S. 910, 130 S. Ct. 3285,

176 L. Ed. 2d 1193,

2010 U.S. LEXIS 3927.

May 17, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 353 Fed. Appx. 789.
No. 09-10050.

#### Joshuaron Antwionne Standifer, Petitioner v. United States.

560 U.S. 914, 130 S. Ct. 3299,

176 L. Ed. 2d 1201,

2010 U.S. LEXIS 3907.

May 17, 2010.

Petition for writ of cer-tiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 359 Fed. Appx. 530.
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Page 1701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-424]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trials.
    Date: February 10, 2009.
    Time: 3 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Paul A. Amstad, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, DHHS/
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, 301-402-7098, <a href="/cdn-cgi/l/email-protection#c8b8a9a5bbbca9ac88a6a1a9a1ace6a6a1a0e6afa7be"><span class="__cf_email__" data-cfemail="3747565a4443565377595e565e5319595e5f19505841">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 6, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-424 Filed 1-12-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
ex10_1.htm








Exhibit 10.1


 


PROMISSORY NOTE


 



	$500,000.00 	Executed at Broward County, Florida
	 	April 9, 2012





 


FOR VALUE RECEIVED, Le@P Technology, Inc., a Delaware corporation with a principal place of business at 5601 N. Dixie Highway, Suite 411, Fort Lauderdale, Florida  33334 ("Maker"), promises to pay to the order of the M. Lee Pearce Living Trust (the "Payee"), the principal sum of FIVE HUNDRED THOUSAND DOLLARS AND NO CENTS ($500,000.00), together with interest at the rate of Three and Three-Quarters Percent (3.75%) per annum due and payable in one lump sum of principal and interest on June 30, 2013.  Principal and interest shall be payable to the Payee at the following address:  16 La Gorce Circle, Miami Beach, FL 33141, or such other place as the Payee may designate.



 




This Promissory Note (this "Note") is issued subject to the following additional terms and conditions:







1.           Type of Payment.  Payment of both principal and interest shall be made in currency of the United States of America which at the time of payment shall be legal tender for the payment of public and private debts.







2.           Manner of Payment.  Payment shall be made to Payee at the Payee's address set forth above or such other place as Payee may designate in writing.







3.           Interest on Overdue Payments.  From and after the date which is fifteen (15) days after the date upon which any payment of principal hereunder becomes due and payable, if the same is not timely paid, interest shall be payable on all sums outstanding hereunder at fifteen percent (15%) per annum.







4.           Miscellaneous.







 (A)          This Note shall be binding upon the Maker and its successors and assigns.







 (B)           If any provision hereof shall be held invalid or unenforceable by any court of competent jurisdiction or as a result of future legislative action, such holding or action shall be strictly construed and shall not affect the validity or effect of any other provision hereof.







 (C)           The validity, interpretation and effect of this Note shall be exclusively governed by, and construed in accordance with, the laws of the State of Florida, excluding the "conflict of laws" rules thereof.







 (D)          This Note may not be amended or modified, nor shall any waiver of any provision hereof be effective, except by an instrument in writing executed by the Maker and Payee.







 (E)           In case suit shall be brought for the collection hereof, or if it is necessary to place the same in the hands of an attorney for collection, the Maker agrees to pay reasonable attorneys’ fees and costs for making such collections.







IN WITNESS WHEREOF, the Maker has caused this Note to be executed as of the day and year first above written.


 




	 	
LE@P TECHNOLOGY, INC.

	 
	 	 	 	 
	 	
By: 

	/s/ Timothy C. Lincoln	 
	 	Name:	Timothy C. Lincoln	 
	 	Title :	Acting Principal Executive Officer
**IN THE SUPREME COURT OF THE STATE OF MONTANA DA**  **24 -**  **0151** SCOTT LARSEN AND KAREN LARSEN , Plaintiff

s and Appellants , v. KEITH SAYERS AND DANIELLE SAYERS , Defendants and Appellees
. ) ) ) ) ) ) ) ) ) ) **ORDER**

Pursuant to Appellants Scott and Karen Larsen’s Mont. R. App. P. 26(1)
mo tion and good cause appearing, IT IS HEREBY ORDERED THAT Appellants are granted an extension of time up to and including **June 12,**  **2024** , in which to file their opening brief in this matter.

Electronically signed by: Bowen Greenwood Clerk of the Supreme Court May 9 2024

05/09/2024

Case Number: DA 24-0151
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         359,300
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       3,967,800
<DEPRECIATION>                               1,440,000
<TOTAL-ASSETS>                               8,334,700
<CURRENT-LIABILITIES>                          108,400
<BONDS>                                      1,340,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   6,886,300
<TOTAL-LIABILITY-AND-EQUITY>                 8,334,700
<SALES>                                              0
<TOTAL-REVENUES>                               881,400
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               615,800
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             127,200
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   138,400
<EPS-PRIMARY>                                      .47
<EPS-DILUTED>                                      .47


</TABLE>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### International Trade Commission

          - [Investigation No. 731-TA-1020 (Review)]

      ( print page 10278)    

## Determination

                    On the basis of the record [1]                                          developed in the subject five-year review, the United States International Trade Commission (Commission) determines, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), that revocation of the antidumping duty order on barium carbonate from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.                

## Background

The Commission instituted this review on September 2, 2008 (73 FR 51315) and determined on December 8, 2008 that it would conduct an expedited review (73 FR 77058, December 18, 2008).

                    The Commission transmitted its determination in this review to the Secretary of Commerce on January 30, 2009. The views of the Commission are contained in USITC Publication 4060 (January 2009), entitled                     *Barium Carbonate from China: Investigation No. 731-TA-1020 (Review).*

Issued: March 4, 2009.

By order of the Commission.

Marilyn R. Abbott,

Secretary to the Commission.

# Footnotes

1.                             The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)).                    
        Back to Citation      

 [FR Doc. E9-5017 Filed 3-9-09; 8:45 am]

BILLING CODE 7020-02-P
109TH CONGRESS 

2D SESSION H. R. 5107

AN ACT

To designate the facility of the United States Postal Service 

located at 1400 West Jordan Street in Pensacola, Florida, as the ‘‘Earl D. Hutto Post Office Building’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2

•HR 5107 EH 

1 SECTION 1. DESIGNATION. 

2 The facility of the United States Postal Service lo3 cated at 1400 West Jordan Street in Pensacola, Florida, 

4 shall be known and designated as the ‘‘Earl D. Hutto Post 

5 Office Building’’. 

6 SEC. 2. REFERENCES. 

7 Any reference in a law, map, regulation, document, 

8 paper, or other record of the United States to the facility 

9 referred to in section 1 shall be deemed to be a reference 

10 to the ‘‘Earl D. Hutto Post Office Building’’.

Passed the House of Representatives May 2, 2006. 

Attest:

Clerk. 

109TH CONGRESS 

2D SESSION H. R. 5107

AN ACT

To designate the facility of the United States PostOffice Building’’. Pensacola, Florida, as the ‘‘Earl D. Hutto Post al Service located at 1400 West Jordan Street in
IN THE SUPREME COURT OF THE STATE OF MONTANA

DA 24-0151

SCOTT LARSEN AND KAREN 

LARSEN,

 Plaintiffs and Appellants,

v.

KEITH SAYERS AND DANIELLE 

SAYERS,

 Defendants and Appellees.

)

)

)

)

)

)

)

)

)

)

ORDER

Pursuant to Appellants Scott and Karen Larsen’s Mont. R. App. P. 26(1) 

motion and good cause appearing,

IT IS HEREBY ORDERED THAT Appellants are granted an extension of 

time up to and including June 12, 2024, in which to file their opening brief in this 

matter.

Electronically signed by:

Bowen Greenwood

Clerk of the Supreme Court

May 9 2024

05/09/2024

Case Number: DA 24-0151
No. 09-9341.

#### Ruben T. Davila, Petitioner v. California.

559 U.S. 1109, 130 S. Ct. 2407,

176 L. Ed. 2d 927,

2010 U.S. LEXIS 3696.

May 3, 2010.

Petition for writ of certio-rari to the Court of Appeal of California, Second Appellate District, denied.
DALE L. WILLIAMS,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D16-3036

_____________________________/

Opinion filed November 1, 2016.

An appeal from an order of the Circuit Court for Duval County.

Steven B. Whittington, Judge.

Dale L. Williams, pro se, Appellant.

Pamela Jo Bondi, Attorney General, and Tayo Popoola, Assistant Attorney 

General, Tallahassee, for Appellee.

PER CURIAM.

AFFIRMED.

LEWIS, ROWE, and KELSEY, JJ., CONCUR.
# C_2016417EN.01000401.xml

| 11.11.2016 | EN | Official Journal of the European Union | C 417/4 |
| --- | --- | --- | --- |

11.11.2016

EN

Official Journal of the European Union

C 417/4

---

EUROPEAN ASYLUM SUPPORT OFFICE

Publication of the final accounts for the financial year 2015

(2016/C 417/12)

The complete version of the final accounts may be found at the following address:

https://www.easo.europa.eu/budget-finance-and-accounting

---